Table 4 Biosimilars of adalimumab
Name of biosimilar | Manufacturer | Approval stage |
|---|---|---|
Cyltezo | Boehringer Ingelheim (Ingelheim am Rhein, Germany) | US FDA (2017) EMA (2017) |
Imraldi(EU)/Hadlima (Korea) (SB5) | Samsung Bioepis (Biogen/Samsung)/ Merck South Korea/USA | EMA (2016) Korea (2017) |
Amjevita(US)/Amgevita (EU)/Solymbic(EU)(ABP 501) | Amgen (Thousand Oaks, CA, USA) | US FDA (2016), EMA (2017) |
GP2017 | Sandoz (Basel, Switzerland) | EMA (2018) |
Exemptia (ZRC3197) | Zydus Cadila (Ahmedabad, India) | DGCI (2014) |
Adfrar | Torrent Pharmaceuticals (Ahmedabad, India) | DGCI (2016) |
Mabura | Hetero Drugs (Ahmedabad, India) | DGCI (2018) |